XTRA:ACTChemicals
Assessing AlzChem Group (XTRA:ACT) Valuation After J.P. Morgan Cuts Voting Stake To 2.90%
AlzChem Group (XTRA:ACT) is back on investors’ radar after J.P. Morgan Investment Management Inc. reported a reduction in its voting rights to 2.90%, a shift that can affect sentiment around the stock.
See our latest analysis for AlzChem Group.
The J.P. Morgan voting rights cut comes at a time when momentum in AlzChem Group’s shares has been strong, with a 1 month share price return of 16.03% and a 1 year total shareholder return of 71.80%. The current share price is €169.4.
If this kind of...